Stockwinners Market Radar for August 21, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:50 EDT SuperCom trading halted, news pending

19:48 EDT SSR Mining says Seabee operations temporarily suspended due to forest fines - SSR Mining announced that operations at Seabee have been temporarily suspended due to forest fires in the vicinity of the mine. As per the company's protocols, staff are being evacuated from the site. There have been no injuries or damage to equipment or infrastructure at this time. Further information will be provided as necessary.

19:29 EDT MGIC 'appreciates' collaboration with GSEs, supports 'prudent' PMIERs changes - Mortgage Guaranty Insurance Corporation commented on the updates by the government sponsored enterprises, Fannie Mae and Freddie Mac, to the Private Mortgage Insurer Eligibility Requirements Available Assets Standards. "We are proud of the critical role private mortgage insurance (MI) plays in the housing finance system. PMIERs operational and risk-based capital requirements provide a strong foundation to serve low down payment borrowers while protecting the GSEs and taxpayers from undue mortgage credit risk and private MIs continue to be strong, well-capitalized counterparties," said Tim Mattke, CEO of MTG. "We appreciate the collaboration with the GSEs and support prudent PMIERs changes," added Mr. Mattke. The latest updates relate to exclusions, concentration limits, and haircuts to investments that qualify as Available Assets and will be implemented over a 24-month phased-in period, with a fully effective date of September 30, 2026. If these changes were effective as of June 30, 2024, without a graduated implementation period, MGIC's Available Assets of $5.8 billion would decrease by approximately 1% or $50 million, and MGIC's PMIERs excess would be $2.3 billion.

18:48 EDT Snowflake CEO: We're seeing strong momentum across the board - In an interview on CNBC's Mad Money, Sridhar Ramaswamy said Snowflake released more products in first half of this year than all of last year. Making products that are easy to use, efficient, and trustable is the core of the company's model, he noted. "Our model is very aligned with what creates value for our customers."

17:59 EDT Kyverna Therapeutics treatment of stiff person syndrome gets orphan designation - According to a post on the FDA's website, Kyverna Therapeutics' treatment of stiff person syndrome received orphan designation. Reference Link

17:33 EDT Radiant Logistics awarded five-year USAID contract - Radiant Logistics announced it has been named, through its wholly-owned subsidiary Radiant Global Logistics, as a global transportation provider for personnel and emergency disaster equipment for the Bureau of Humanitarian Assistance, in conjunction with USAID. This contract is a continuation of the confidence placed by USAID in the Humanitarian and Governmental arm of Radiant for critical missions around the globe. Radiant has consistently performed with the dedication and urgency that is required for search and rescue projects, including mission critical support following the earthquake in Turkiye, delivering tarps and blankets following the cyclone in Vanuatu, along with countless other projects.

17:30 EDT Zoom Video sees Q3 deferred revenue up 5% - Sees FY25 free cash flow $1.58B-$1.62B. Says drivers of total revenue included acquiring new customers. Says does not think the customer should be charged for AI companion. Comments and guidance taken from Q2 earnings conference call.

17:24 EDT Zoom Video CFO Kelly Steckelberg to resign, will remain through Q3 earnings - In a regulatory filing, Zoom Video announced Kelly Steckelberg notified the company that she intends to resign from her role as the company's CFO. The company said Steckelberg's decision was not the result of any disagreement with the company. The company has commenced a search process to identify Steckelberg's successor. The company entered into a transition and separation agreement with Steckelberg in connection with her departure from the company. Pursuant to the transition agreement, Steckelberg will continue to serve as the company's CFO through the release of the company's earnings for the fiscal quarter ending October 31. Commencing October 10, she will be serving in this role on a part-time basis. During the transition period and the part-time period, Steckelberg will be entitled to receive her base salary at the same full-time rate as it was prior to the transition period and will continue to be eligible for the company's standard benefits. During the transition period, Steckelberg's outstanding equity awards of the company will continue to vest pursuant to their terms.

17:15 EDT Nauticus Robotics appoints John Symington as General Counsel - Nauticus Robotics appointed John Symington as General Counsel of the company on August 14. Nick Bigney recently announced his departure and the two are working together through the transition period. Symington has over 20 years' experience in-house, including serving as General Counsel at Frank's International and Seadrill, complemented by 10 years in private practice. His industry experience includes oilfield services, maritime operations, manufacturing, and software.

17:00 EDT Allete shareholders approve transaction with CPP Investments, GIP - Allete announced that its shareholders voted today to approve the company's proposed transaction with Canada Pension Plan Investment Board and Global Infrastructure Partners at a special meeting of shareholders. As previously announced, under the terms of the merger agreement, CPP Investments and GIP will acquire all outstanding common shares of ALLETE for $67 per share in cash, or $6.2B, without interest. "We thank our shareholders for this strong demonstration of support for our transaction with CPP Investments and GIP, and for their investment in ALLETE over the past decades," said ALLETE Chair, President, and CEO Bethany Owen. "Having reached this important milestone, we are now one step closer to realizing the meaningful benefits we see ahead for all ALLETE stakeholders as the result of this partnership. We will continue to work closely with our partners in the months ahead to complete this transaction and enter our next chapter of growth for ALLETE, while continuing our excellent customer service, commitments to our communities, and opportunities for our employees." Based on the preliminary vote count from today's special shareholder meeting, approximately 97% of votes cast were in favor of the proposed transaction, representing approximately 74% of all outstanding shares. The final voting results will be reported in a Form 8-K filed with the U.S. Securities and Exchange Commission.

16:47 EDT First Capital increases quarterly dividend 7.4% to 29c per share - First Capital has declared a quarterly cash dividend of 29c per share of common stock. The dividend will be paid on September 27 to shareholders of record as of September 13. This represents an increase of 2c per share, or 7.4%, compared to the most recent dividend paid on June 28.

16:27 EDT N2OFF enters EU PV market with initial 111 MW project In Germany - N2OFF entered its first EU PV market with initial 111 MW project In Germany, as part on an agreement with Solterra Renewable Energy together with a number of private investors, to fund up to EUR 8M solar PV projects, as previously announced on July 31. The first project which was agreed upon is planned in Melz, Germany, with a total capacity of 111 MWp for which the company and investors will loan an aggregate amount of EUR 2.08M. The project has been approved by the municipality of Melz and additionally received attention for a potential grid connection by a large regional energy service provider in Germany. Pursuant to the agreement, N2OFF and the investors will finance the project up to an aggregate of $2.2M in order to assist the project in reaching its goal of obtaining RTB status. The loan will be given based on accomplished milestones, with an accrued interest at a rate of 7% per annum and provide the company and investors with up to 50% of the rights to the net earnings. Furthermore, the agreement also contemplates for a right of refusal in favor of the company and the investors, for additional project investments of up to EUR 6M.

16:22 EDT Microsoft sees Q1 Azure, cloud services revenue up 33% in constant currency - Microsoft sees Q1 365 Commercial cloud revenue up 15% in constant currency

16:20 EDT Phoenix Motor receives noncompliance notification from Nasdaq - Phoenix Motor announced that it received a delinquency notification letter from Nasdaq on August 16 due to the company's non-compliance with Nasdaq as a result of the company's failure to timely file its quarterly report on Form 10-Q for the quarterly period ended June 30. Previously, the company received a delinquency notification from Nasdaq that the company no longer complied with the listing rule as it had not yet filed its Form 10-Q for the quarterly period ended March 31.

16:17 EDT Samsara names Meagen Eisenberg CMO - Samsara announced it has named Meagen Eisenberg as Chief Marketing Officer. Eisenberg joins Samsara from Lacework, where she served as Chief Marketing Officer since 2022. Prior to Lacework, Eisenberg served as Chief Marketing Officer at MongoDB and TripActions and has nearly 25 years of leadership experience scaling high-growth companies. Eisenberg will report directly to Sanjit Biswas, Samsara's CEO and Co-founder, and will join the company on August 28, 2024. "We are excited to welcome Meagen to our team during this pivotal time for Samsara," said Sanjit Biswas, CEO and Co-founder of Samsara. "Meagen's deep industry expertise and understanding of our customers and market dynamics will be invaluable as we continue to push the boundaries of innovation. I'm confident that her vision will help us forge even stronger connections with our customers and expand our presence in the market."

16:16 EDT Argan CFO Deily to retire, Baugher named next CFO - Argan announced that Chief Financial Officer, Richard H. Deily, 71, will retire effective September 15, 2024, after a distinguished 40-year career in senior financial management, which includes a 17-year tenure with the Company. Josh Baugher, who has served as Vice President and Corporate Controller for Argan since 2022, will succeed Mr. Deily as Chief Financial Officer. Deily joined Argan in October 2007 as Corporate Controller and was named Vice President, Corporate Controller in January 2015. He has served as Chief Financial Officer since August 2022. Before joining Argan, his career included senior financial management roles with publicly traded companies in various industries, including construction, commercial software, telecommunications, government contracting and electronics manufacturing.

16:12 EDT Ohio Valley Banc Corp extends stock buyback program - Ohio Valley Banc Corp.'s Board of Directors has authorized the extension date of its existing stock buyback program to August 31, 2025. The program was originally set to expire August 31 of this year. With the extension, the share repurchase program will continue to authorize the repurchase of up to $5M in shares of the company's outstanding common stock. As of August 21, the company had repurchased approximately $2,967,000 in common stock. The program may be terminated or amended by the Board at any time prior to the expiration date.

16:11 EDT SOS Limited gets NYSE non-compliance letter regarding ADS trading price - SOS Limited announced the Company has received a letter from the New York Stock Exchange dated June 27, , notifying SOS that it is below compliance standards due to the trading price of SOS's American depositary shares the "ADSs" .Pursuant to NYSE rule 802.01C, a company will be considered to be below compliance standards if the average closing price of a security as reported on the consolidated tape is less than $1.00 over a consecutive 30 trading-day period. Once notified, the company must bring its share price and average share price back above $1.00 by six months following receipt of the notification. The company can regain compliance at any time during the six-month cure period if on the last trading day of any calendar month during the cure period the company has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. In the event that at the expiration of the six-month cure period, both a $1.00 closing share price on the last trading day of the cure period and a $1.00 average closing share price over the 30 trading-day period ending on the last trading day of the cure period are not attained, the NYSE will commence suspension and delisting procedures.

16:09 EDT SS&C raises quarterly dividend to 25c from 24c per share - The dividend is payable on September 16 to stockholders of record as of the close of business on September 3.

16:04 EDT Siga Technologies announces new DOD contract for Tpoxx - Siga announced a new contract with the U.S. Department of Defense, or DOD, for the procurement of approximately $9M of Tpoxx. This award is comprised primarily of oral Tpoxx, with a small amount of intravenous Tpoxx, and represents the third procurement contract award from the DOD over the past three years. Siga has been collaborating with the DOD's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense to develop the Post-exposure Prophylaxis indication for oral Tpoxx, and this work has been supported by a development contract with a value of approximately $27M as well as a Cooperative Research and Development Agreement. Inclusive of this award, Siga currently has approximately $154M of outstanding oral and IV Tpoxx orders, of which more than 85% of this amount was generated within the past three months.

15:49 EDT Geovax Labs Inc trading halted, volatility trading pause

14:18 EDT Flanigan's trading resumes

12:36 EDT Lattice Semiconductor CFO Luther sells over 20,000 common shares - In a regulatory filing, Lattice Semiconductor CFO Sherri Luther disclosed the sale of 20,632 common shares of the company on August 20 at a price of $48.8893 per share.

12:01 EDT U.S. video game spending rose 10% y/y in July, says Circana - Circana analyst Mat Piscatella said that projected U.S. spending on video game hardware, content and accessories reached $4.8B in July 2024, gaining 10% when compared to a year ago. 2024 year-to-date spending is now 2% higher than a year ago, at $32.1B. Video game content spending increased 10% in July compared to a year ago, as 29% growth in console content spending and an 8% increase in mobile was partially offset by a 6% drop in spending on PC, cloud, and non-console VR content. July video game hardware spending grew 12% when compared to a year ago, to $326 million. Growth in spending on Sony's (SONY) PlayStation 5 (+25% vs YA) and Microsoft's (MSFT) Xbox Series (+48%) hardware was partially offset by a 44% drop in spending on Nintendo Switch (NTDOY). PlayStation 5 led the month's hardware market in unit and dollar sales, with Xbox Series ranking 2nd across both measures. July 2024 is the first month with year-on-year growth in video game hardware spending since the 2% increase seen during December 2023. Other publicly traded companies in the space include Electronic Arts (EA), GameStop (GME), NetEase (NTES), Take-Two (TTWO), Tencent (TCEHY) and Ubisoft (UBSFY). Reference Link

12:00 EDT Macy's falls -11.6% - Macy's is down -11.6%, or -$2.05 to $15.69.

12:00 EDT Ginkgo Bioworks rises 9.3% - Ginkgo Bioworks is up 9.3%, or 72c to $8.43.

12:00 EDT Keysight Technologies rises 12.2% - Keysight Technologies is up 12.2%, or $16.97 to $155.54.

11:56 EDT B. Riley jumps 5% to $5.75 after Bloomberg report of Oaktree stake talks

11:46 EDT Western Asset Management's Leech takes leave of absence amid SEC investigation - In a regulatory filing earlier, Western Asset Management Company announced that it has appointed Michael Buchanan to Chief Investment Officer. Buchanan had served as co-Chief Investment Officer with Ken Leech, who is on a leave of absence, effective immediately. In line with the company's succession plan, Buchanan has been elevated to Chief Investment Officer. Along with his responsibilities as Chief Investment Officer, Buchanan has assumed leadership of all global investment management responsibilities. As disclosed in the 10-Q filed by Franklin Resources in July, the company launched an internal investigation into certain past trade allocations involving treasury derivatives in select Western Asset-managed accounts. The company is also cooperating with parallel government investigations. Leech recently received a Wells Notice from the Staff of the U.S. Securities and Exchange Commission, and is on a leave of absence to focus on this matter. The company will take action as warranted based on any findings after the conclusion of its investigation.

11:39 EDT Northwest Bank appoints Sean Morrow as interim treasurer - Northwest Bank has named Sean Morrow as Interim Treasurer effective August 23. He will replace Corporate Treasurer and EVP of Finance and Accounting Jeffrey Maddigan, who is leaving to pursue an opportunity outside of the bank. In this role, Morrow will oversee the treasury function, including managing the bank's interest rate, liquidity and capital efforts; managing the securities investment portfolio; facilitating interest rate swaps and ensuring the bank meets its regulatory and risk expectations. A seven-year veteran of Northwest, he joined the bank as treasury risk manager and most recently served as assistant treasurer.

11:29 EDT Cosmos' Cana completes facility upgrades, secures manufacturing agreement - Cosmos Health's Cana Laboratories has completed the latest upgrades to its manufacturing capabilities and capacities and secured a contract manufacturing agreement with Provident Pharmaceuticals. Cosmos Health completed its acquisition of Cana in July 2023 and has since invested in upgrading Cana's Athens facility, which is licensed under European Good Manufacturing Practices and certified by the European Medicines Agency laying the foundation for future growth. As a result, Cana is now ramping up revenue generation from manufacturing its own products as well as those of third parties. Cana's facilities can accommodate a wide range of pharmaceuticals, including tablets, capsules, syrups, nasal sprays, creams, gels, and ointments. In line with this strategy, the Company has entered into a contract manufacturing agreement with Provident to support their growth aspirations. Specifically, the contract relates to the manufacturing of 4.32 million units of DE3-SOLE OR.SOL.SDC 25000 IU/2.5ML.

11:17 EDT TJX CEO: Q3 'off to a strong start,' 'will not be complacent'

10:33 EDT Cognizant appoints Rajesh Varrier as global head of operations - Cognizant announced the appointment of Rajesh Varrier as Global Head of Operations, effective September 2, 2024. Additionally, he will be appointed as Chairman & Managing Director, India, assuming the role October 1, 2024, as Rajesh Nambiar leaves Cognizant to become president of NASSCOM. Varrier will be an Executive Vice President of Cognizant, reporting to Ravi Kumar S, Cognizant's CEO. Varrier will be based in Bangalore, India. As Global Head of Operations and Chairman & Managing Director, India, Varrier's responsibilities will include operations, Delivery Excellence, workforce planning, India Leadership Council, expansion in India and other key responsibilities. Importantly, he will provide regional leadership for Cognizant's India-based employees with a strong emphasis on driving company transformation programs, and representing the company as it executes its growth plan across India. Prior to joining Cognizant, Rajesh Varrier served as EVP, Head of Global Services and Infosys Americas, as well as Global Head of Infosys' Digital and Microsoft businesses.

10:07 EDT Bright Green enters partnership with Benuvia Pharmaceuticals - Bright Green has signed a letter of intent to supply its DEA-approved marijuana extracts and plant-based psychedelics to Benuvia Operations as well as psychedelic molecules currently under investigation for clinical use. This completely homegrown agreement signals Bright Green's ability and commitment to supply US pharmaceutical partners with high quality organic materials. As part of the supply agreement proposed in the LOI, Benuvia intends to leverage Bright Green's unique position to produce Schedule I & II raw materials in full compliance with Good Agricultural and Collection Practices, Good Manufacturing Practices, and the DEA, all within the USA, to produce domestically manufactured cGMP pharmaceutical-grade Active Pharmaceutical Ingredients for US and global markets.

10:01 EDT TD Synnex, Janam Technologies announce new distribution agreement - Janam Technologies announced a new distribution agreement with TD SYNNEX. TD SYNNEX will connect its partner community to Janam's hardware and solutions to help businesses of all types and sizes improve productivity across line-of-business applications. Janam's rugged mobile computers, RFID readers and accessories are available immediately to partners in the U.S. and Canada.

10:00 EDT Keysight Technologies rises 13.9% - Keysight Technologies is up 13.9%, or $19.30 to $157.87.

10:00 EDT Dycom falls -7.3% - Dycom is down -7.3%, or -$14.20 to $180.00.

10:00 EDT Macy's falls -12.3% - Macy's is down -12.3%, or -$2.19 to $15.55.

09:48 EDT FinVolution falls -6.0% - FinVolution is down -6.0%, or -34c to $5.36.

09:48 EDT Macy's falls -12.1% - Macy's is down -12.1%, or -$2.15 to $15.59.

09:47 EDT Keysight Technologies rises 11.9% - Keysight Technologies is up 11.9%, or $16.54 to $155.11.

09:43 EDT Rezolve AI Ltd trading halted, volatility trading pause

09:35 EDT IPX Stock trading resumes

09:31 EDT Emerson Ventures invests in Symmera - Emerson announced it has made a strategic investment through its corporate venture capital arm Emerson Ventures in Symmera, an early-stage company simplifying device authentication and data protection. Boulder Ventures will co-invest with Emerson.

09:28 EDT UTime announces AI health strategy, strategic collaboration with Dr. Ehud Baron - UTime is pleased to announce its ambitious strategy for advancing AI-driven health solutions. Recognizing the growing value and potential of smart health technologies, UTime is committing significant investments to expand its smart medical wearable products business. In strategic collaboration with Dr. Ehud Baron, a renowned figure in medical technology innovation, UTime is set to enhance its offerings in blood pressure measurement and extend into hemodynamic and health mapping products. Dr. Baron will collaborate with UTime's team to develop comprehensive plans for a diverse range of health product lines. The initial focus will be on optimizing UTime's flagship blood pressure monitoring watch. Upon successful development, the company plans to further expand its product range to address a wide spectrum of smart healthcare needs. Additionally, UTime intends to launch a variety of products focusing on smart detection of key health indicators, such as heart rate and sleep monitoring devices.

09:11 EDT Lexaria Bioscience announces interim results from diabetes animal study - Lexaria Bioscience has received 4-week and 8-week blood glucose results from ongoing animal study WEIGHT-A24-1. DehydraTECH-liraglutide and two DehydraTECH-CBD formulations were the top performers in the Study at day 56, with blood sugar level reductions of 2.50%, 1.90% and 1.53% respectively. This appears to support Lexaria's belief that DehydraTECH-CBD may have utility, especially if used together with a GLP-1 drug, in diabetic control. Animal testing of combination DehydraTECH-CBD with DehydraTECH-GLP-1 drugs is ongoing and in the final phases of the Study. For context, in Lexaria's diabetic animal study DIAB-A22-1 reported on March 2, 2023, the obese control group of animals that received no treatment experienced 16.7% blood sugar concentration increases, relative to baseline by day 56 of that study. In the current Study, each of the 8 active groups of animals either experienced a smaller increase, or an actual decrease in blood sugar level relative to baseline as compared to the obese control group in the previous study. Interestingly, none of the animals receiving semaglutide experienced actual decreases by day 56 although some decreases were observed at day 28.The continued relative outperformance of DehydraTECH liraglutide is extremely interesting, in part because of Lexaria's proprietary DehydraTECH technology and its applicability to GLP-1 molecules. In other human studies, semaglutide tends to outperform liraglutide in blood sugar control, when not processed with DehydraTECH. Liraglutide is currently available commercially by Novo Nordisk sold under the brand names Victoza and Saxenda, but the related patents have begun to expire and open the door to new competitors. For example, Teva Pharmaceutical Industries recently launched the first generic injectable version of this GLP-1 drug. Although liraglutide was administered as an oral DehydraTECH-enabled dose in this Study, it is currently only sold and prescribed as a subcutaneous injection. The Study is ongoing and additional results are expected soon.

09:08 EDT Sify Technologies appoints Sharad Agarwal as CEO, Sify Infinit Spaces - Sify Technologies announced the appointment of Mr. Sharad Agarwal as the CEO of Sify Infinit Spaces Limited, wholly owned subsidiary of Sify Technologies Limited. Prior to Sify, Sharad was at Vantage, where he was mandated to build their Data Center business. This was preceded by a long stint at Amazon Web Services where he front-ended capacity delivery for an APAC region.

09:07 EDT American Vanguard withdraws Dacthal registration - American Vanguard announced that, following its decision in April to voluntarily stop sales of Dacthal herbicide products, the company has submitted to the Environmental Protection Agency, or EPA, voluntary cancellation requests for all of its federal registrations of those products. Those registrations are currently the subject of an emergency suspension order that was issued by EPA on August 6. In connection with its action, the company made the following statements. "While the Company continues to question EPA's conclusions in support of the suspension, we believe that the best course of action is to voluntarily cancel registrations of this product. We are working apace with both state and federal authorities to effect product return and to remove Dacthal from channels of distribution. It is the Company's position that product stewardship be international in scope; thus, we will now proceed to voluntarily cancel all international registrations as well. It is important to note that EPA's findings are based upon the test results of a single, relatively new study that the Company had provided to the agency over two years ago which showed an effect on fetal rodents at certain dose levels. As is typically the case with such studies, the observed effect was extrapolated to indicate a potential effect upon human beings. The suspension order, then, was issued by EPA on the premise of preventing potential harm, rather than in response to an actual, reported harm. The Company had been working with the EPA in good faith for over one year to identify risk mitigation measures that might alleviate concerns and allow continued use of high-benefit use patterns. However, these measures apparently did not give the EPA sufficient certainty at the time. The Company was also discussing with the EPA the potential for completion of additional toxicology and exposure studies that may have alleviated risk concerns, had they been afforded time to proceed. The Company nevertheless thanks EPA for expending time and resources to consider and evaluate the many proposed risk mitigation measures."

09:07 EDT TNF Pharmaceuticals preparing to advance its lead program, MYMD-1 - TNF Pharmaceuticals announced that it is preparing to advance its lead program, MYMD-1, through fully funded mid-stage clinical trials. MYMD-1 is a small molecule shown to block excessive activity of TNF-alpha, TNF-a, in the blood to regulate the immuno-metabolic system. The next clinical studies of MYMD-1 will further explore the drug's efficacy in sarcopenia/frailty following statistically significant positive results from an earlier Phase 2 clinical study. "In our view, MYMD-1, if approved, could be the first orally administered TNF-alpha inhibitor drug and the first and only therapy for sarcopenia, a common age-related disorder that causes a prolonged decline in physical function. The success of our clinical strategy and regulatory pathway to date supports MYMD-1's potential to disrupt the TNF-alpha inhibitor market," said Mitchell Glass, M.D., President and Chief Medical Officer of TNF Pharmaceuticals. "As we prepare for our next fully funded clinical studies in sarcopenia/frailty, we also have open INDs for Phase 2 trials of MYMD-1 in two additional chronic inflammatory conditions, rheumatoid arthritis and Hashimoto's thyroiditis, which we could pursue with the support of non-dilutive domestic and/or international development partnerships. A partner outside of the U.S. could potentially help us accelerate the timeline to commercialization of our lead asset. "Each of MYMD-1's indications provide solid measures of Company value," Dr. Glass continued. "We are excited about the positive data we have gathered so far for our lead asset. Our next steps, to be revealed soon, will extend our reach toward significant and sustainable value creation, and long-term Company growth."

09:05 EDT Comscore announces integration of CCR into Basis Technologies platform - Basis Technologies announced an integration of Comscore's omnichannel ad measurement solution, Comscore Campaign Ratings, CCR, into Basis platform. Users of the Basis advertising automation platform can now easily access Comscore's deep person-level insights for campaign measurement, validation, and optimization at the individual market level. "We are excited to collaborate with innovators like Basis Technologies to enhance programmatic advertising through our omnichannel measurement solutions," said Steve Bagdasarian, Chief Commercial Officer at Comscore. "This partnership highlights our dedication to boosting programmatic media performance by providing actionable campaign measurement data with precision and speed."

09:03 EDT Mullen's Bollinger announces to start roduction on Class 4 EV trucks - Mullen Automotive announces its subsidiary, Bollinger Motors, is planning to begin production of saleable units of the Bollinger B4 Chassis Cab on Sept. 16, 2024. Deliveries and revenue recognition of the B4 EV truck is expected to begin in October 2024. The Bollinger B4 Chassis Cab, an all-new Class 4 commercial truck, was designed from the ground up with extensive fleet and upfitter input. Bollinger Motors' unique, purpose-built EV chassis design encloses and protects the 158-kwh battery pack and components to offer unparalleled capability and safety in the commercial market. Bollinger Motors is partnering on production with Roush Industries, which provides contract manufacturing services from its facility in Livonia, Michigan.

09:03 EDT Target 'pleased' with progress on shrink, ahead of expectations - "Encouraged" by strength of same-day and drive up services. Says in "early days" of building out food business.

09:01 EDT Grubhub announces expansion of its Campus Dining business - Grubhub announced the expansion of its Campus Dining business to more than 60 schools across the country. Grubhub Campus Dining is the higher-ed-focused part of Grubhub's business that serves college students and directly integrates mobile ordering into campus meal plans. Last year was the strongest yet for Grubhub Campus Dining, and with these new additions, Grubhub now reaches half a million new students and serves a total of more than four and a half million students. New campus partners include the University of Alabama at Birmingham, the University of Tampa, the University of Missouri, Howard University and Tulane University. With the addition of these campuses, Grubhub now works with more than 360 universities, up 21 percent from last year.

08:48 EDT Sonoma Pharmaceuticals enters distribution agreement for wound care products - Sonoma Pharmaceuticals has entered into a distribution agreement with a global healthcare distributor for the marketing and distribution of its wound care products in the United States. The agreement provides for the distribution of Sonoma's wound care products through an existing and extensive network of hospital systems and other healthcare channels in the United States.

08:46 EDT Oragenics completes spray-dried formulation, filling in nasal device for ONP-002 - Oragenics announced the completion of its spray-dried formulation and filling in the nasal device for its lead candidate, ONP-002, for concussion. ONP-002 is a new chemical entity (NCE) designed to target the brain through delivery into the nasal cavity. The prefilled formulation is intended to provide the needed drug-device dosing for the planned Phase IIa clinical trial in concussed patients. For the trial, the Company produced both placebo and ONP-002 drug for use in the Phase IIa clinical trial to be conducted in Australia. The work included the production of ONP-002 as a spray-dried nanoparticle formulation, loading of the powder in Oragenics' novel breath-propelled intranasal device, and initiating a stability program of both the drug formula alone and within the device. The Phase IIa clinical trial is expected to enroll 40 concussed patients who will receive 1:1 either placebo or the ONP-002 drug, with doses given twice a day for five consecutive days following injury. The trial aims to start treatment within 8 hours of the injury in the emergency department. It is anticipated that patient-reported outcomes and blood biomarkers will be included in the evaluation.

08:43 EDT Waymark Gardens expands use of Iveda Solutions for operational efficiency - Iveda announced that Waymark Gardens, a senior living facility in Glendale, AZ, has expanded its use of Iveda's sensor-based, HIPAA-compliant solution, IvedaCare, with the integration of Iveda IvedaAI - the world's fastest AI video search platform, enabling real-time object and incident detection - will be deployed in public spaces to enhance safety and operational efficiency. IvedaAI is now deployed in Waymark Gardens' public corridors, allowing for real-time detection of falls and other critical incidents, ensuring swift responses and added security for both residents and staff. This powerful combination of IvedaCare and IvedaAI provides a comprehensive solution for senior living facilities across the nation, further advancing the execution of Iveda's subcontract with Movement Interactive under the $1.032 billion, eight-year Veterans Affairs contract for remote patient monitoring.

08:40 EDT Intelligent Bio announces installation of over 1,000 IFD Screening Readers - Intelligent Bio Solutions announced the installation of over 1,000 Intelligent Fingerprinting Drug, IFD, Screening Readers with customers as of June 30, 2024. This achievement marks a significant milestone for INBS, underscoring the growing demand for the Company's advanced drug screening technology. In the fiscal year ending June 30, 2024, the Company sold 407 readers, a 26% increase from 323 readers sold in the prior fiscal year. As of June 30, 2024, the total number of installed readers was 1,037, a 65% increase from 630 installed readers as of June 30, 2023.

08:39 EDT Bridgeline Digital 's HawkSearch introduces MSM feature - Bridgeline Digital has unveiled Multi-Site Management, MSM, the latest new feature for HawkSearch. HawkSearch's new Multi-Site Management, MSM, allows organizations to centrally manage multiple websites, while still providing local sites the flexibility to tailor content for their markets. MSM was developed for a HawkSearch customer managing campaigns across 750 websites. MSM is ideal for scenarios where multiple teams oversee numerous local sites, providing streamlined and efficient management of both local and global merchandising campaigns.

08:38 EDT Horizon Aircraft appoints Tom Brassington as CTO - New Horizon Aircraft (HOVR) announces that Tom Brassington has been appointed as Chief Technology Officer. Tom joins from Lilium (LILM) where he held the position of Head of System Design Engineering. He takes up his new role at Horizon Aircraft at the end of October 2024.

08:37 EDT KULR Technology announces resignation of COO Cochran, re-allocated oversight - KULR Technology Group announced the mutually agreed upon resignation of Keith Cochran as President and Chief Operating Officer, COO, effective August 20, 2024. KULR has re-allocated the oversight of its day-to-day operations among its executive level management, headed by Chief Executive Officer, Michael Mo. KULR's Board believes the new leadership structure fully aligns with the Company's accelerated strategic shift to Webster, Texas, which the Company has designated as its principal executive office. While Webster is already the Company's largest office, its San Diego location will continue to be a critical innovation hub.

08:36 EDT HealthEquity to kick off second annual HSA Week - HealthEquity will kick off the second annual HSA Week on August 26. The weeklong event will include a variety of resources to educate workers and companies about HSAs and their potential to improve healthcare savings and financial stability. According to a recent HealthEquity research study, roughly 40% of employees lack confidence in their health plan decisions and more than half wonder at times if they have chosen the right plan for their needs. The good news is that education can help. The study also found that employees who have an excellent understanding of their benefits options are almost 4x more confident they chose the right plan for their needs, when compared with those who have a poor understanding.

08:36 EDT Principal Financial names Deanna Strable President and Chief Operating Officer - Principal Financial Group announced that Deanna Strable, executive vice president and current chief financial officer, is named president and chief operating officer. Dan Houston will continue to serve as CEO and Chairman of the Board. Deanna has been instrumental in driving strategy, financial results, and operations to enable Principal to grow and continue to create value for our customers, shareholders, and employees," said Houston. "Her appointment as president and COO reflects her extensive experience and proven leadership within the organization, and I am excited to continue our strong partnership."

08:35 EDT Smart for Life announces update on prospective acquisitions - Smart for Life announced the potential expansion of the Company's acquisition pipeline and provided an update on its M&A activities. The Company is currently negotiating the acquisition of four profitable Health & Wellness targets with several additional prospects in exploratory discussions as part of the Company's post-restructuring initiatives. These acquisitions include the following: Purely Optimal Nutrition - Previously announced acquisition. The Company and the Purely Optimal management are actively collaborating on the restructuring of their sales initiatives to improve Purely Optimal's profitability prior to closing of the acquisition. Liquid Manufacturer - Contract manufacturer with sales of approximately $12 million and profitable in the prior fiscal year. Established Supplement Brand - Historical sales of approximately $10 million annually and profitable through nutraceutical products. Wholesale Manufacturer and Distributor - Generating revenue of approximately $8 million and profitable in retail channels. Smart for Life is seeking profitable companies in the nutraceutical industry across the United States as well as prospective foreign acquisitions, preliminarily targeting companies with between $5 million and $25 million in annual revenue. We pursue targets that are committed to innovation, high quality standards, organic growth, and that have a keen interest in partnering with a publicly held organization.

08:34 EDT PainReform announces study observations on delivery method for PRF-110 - PainReform announced the successful determination of the optimal delivery method for PRF-110 in bunionectomy procedures. This achievement marks a significant milestone aimed at advancing PRF-110 as a leading post-surgical pain management solution. Key Findings from the Phase III Study: PRF-110 was observed to provide thorough coverage of both nerve endings and surrounding tissue surfaces. This is crucial for maximizing pain relief, as full coverage ensures that the product remains in place throughout wound closure and delivers the intended dose directly to the target area. PRF-110 demonstrated superior adhesion and location adherence over the wound bed. Additionally, PRF-110 resolved another competitor's product issue, being too viscous and becoming increasingly difficult to manage when interacting with physiological fluids. PRF-110 exhibited optimal viscosity and uniformity, maintaining its effectiveness even in the presence of physiological fluids. To ensure comprehensive coverage within the wound geometry, PRF-110 was administered using a cannula connected to the syringe's Luer lock. This method enabled precise delivery to all parts of the wound, further enhancing the product's therapeutic impact.

08:33 EDT Sabre signs long-term distribution agreement with Delta Air Lines - Sabre (SABR) has finalized a multi-year renewal of its distribution agreement with Delta Air Lines (DAL). The long-term agreement enables Sabre-connected travel agents to access both traditional EDIFACT and New Distribution Capability content, enhancing their ability to provide comprehensive travel offers to their customers. Earlier this year, Delta announced details of its selling and servicing transformation, which includes NDC. Sabre and the airline will collaborate on the integration of NDC content into Sabre's travel marketplace to support this strategy.

08:32 EDT Wheels Up CFO Todd Smith to leave company, Eric Cabezas named interim CFO - Wheels Up Experience announced two transitions on its executive leadership team, as CFO Todd Smith will be leaving the company for a new role, and Chief Legal Officer Laura Heltebran will be departing to pursue other opportunities. Starting September 9, Matthew Knopf will be joining Wheels Up as Chief Legal Officer and Secretary, with Eric Cabezas acting as interim CFO while a search is conducted for Smith's replacement. Cabezas joined Wheels Up in 2019 and previously acted as interim CFO during a period of transition for the company. In his role as SVP of Finance, Cabezas is responsible for providing key financial support to Wheels Up's commercial, operational and functional teams. He was also instrumental in the process of securing the company's 2023 capital investment.

08:17 EDT Mitek Systems and Alogent team on expanding 'check fraud epidemic' - Mitek Systems announces the expansion of their partnership with Alogent. Alogent will integrate Mitek's Check Fraud Defender, CFD, into its web-based enterprise deposits automation solution, Unify. Using a unique combination of patented imaging science, machine learning, and artificial intelligence to analyze checks from all channels in real-time, one customer reported a reduction in losses of $16M after using CFD for a few months. "As transaction fraud tactics become more sophisticated, effective mitigation is essential to safeguard our clients' operations," said Ashish Bhatia, VP Product Management, Alogent. "By integrating Mitek's Check Fraud Defender with our Unify platform, we provide our bank and credit union partners with advanced AI-driven tools for risk mitigation across all deposit channels, while maintaining a seamless user experience for account holders. This partnership highlights Alogent's commitment to innovation and our dedication to upholding the highest standards of security and trust in the banking industry."

08:08 EDT Ford broadens electrification strategy, announces $400M charge - Ford is taking additional actions to deliver an electric vehicle business and add more propulsion choices for customers that generate lower CO2 emissions. The plan includes adjusting the company's North America vehicle roadmap to offer a range of electrification options designed to speed customer adoption - including lower prices and longer ranges. In its fully electric portfolio, Ford will prioritize the introduction of a new digitally advanced commercial van in 2026, followed by two new advanced pickup trucks in 2027 and other future affordable vehicles. Ford also realigned its U.S. battery sourcing plan to reduce costs, maximize capacity utilization, and support current and future electric vehicle production. In addition to adjusting the cadence of product launches and realigning battery sourcing, Ford now plans to leverage hybrid technologies for its next three-row SUVs. As a result of this decision, the company will take a special non-cash charge of about $400M for the write-down of certain product-specific manufacturing assets for the previously planned all-electric three-row SUVs, which Ford will no longer produce. These actions may also result in additional expenses and cash expenditures of up to $1.5B and the company will reflect those in the quarter in which they are incurred, as a special item. The rollout of Ford's next generation of electric vehicles begins with a commercial van that will be assembled at Ford's Ohio Assembly Plant starting in 2026. The first affordable vehicle off this new low-cost, highly efficient platform will be a mid-sized electric pickup launching in 2027 that is expected to cater to customers who want more for their money - more range, more utility, more useability. Ford is retiming the launch of its electric truck code-named "Project T3" to the second half of 2027. Taking all the learnings from F-150 Lightning customers, the truck will offer features and experiences never seen on any Ford truck, including upgraded bi-directional charging capability and advanced aerodynamics. The truck will be assembled at BlueOval City's Tennessee Electric Vehicle Center. Retiming the launch allows the company to utilize lower-cost battery technology and take advantage of other cost breakthroughs while the market continues to develop. Ford will develop a new family of electrified three-row SUVs which will include hybrid technologies that can offer breakthrough efficiency, performance benefits and emissions reductions versus pure gas vehicles and extend the range of the vehicle on road trips relative to pure electric vehicles. In addition, the next-generation F-Series Super Duty pickup will have a range of propulsion options, building on Ford's hybrid truck sales leadership with the F-150 and Maverick. Ford realigned battery sourcing to support both electric vehicle and other emerging electrified vehicle applications to unlock cost reductions, improve capital efficiency, and qualify for Inflation Reduction Act production and consumer tax credits. Ford and LG Energy Solutions are targeting to move some Mustang Mach-E battery production from Poland to Holland, Michigan, in 2025 to qualify for Inflation Reduction Act benefits. The BlueOval SK joint venture's Kentucky 1 plant will manufacture cells for the current E-Transit with enhanced range and F-150 Lightning beginning mid-2025, delivering significant cost improvements coming online earlier than planned. BlueOval SK at BlueOval City in Tennessee will produce cells starting in late 2025 for Ford's new electric commercial van to be built at Ford's Ohio Assembly Plant. Those same cells will be sourced to later power the next-generation electric truck to be assembled at BlueOval City and future emerging technology electrified vehicles. This common cell strategy gives Ford sourcing flexibility for manufacturing across multiple segments and electrified platforms as the market continues to evolve. Lithium iron phosphate battery production is on track to begin in 2026 at BlueOval Battery Park Michigan - America's first automaker-backed LFP battery plant - qualifying for Inflation Reduction Act benefits and giving Ford one of the lowest-cost battery cells in North America.

08:06 EDT US Antimony announces acquisition of mining claims in Alaska - United States Antimony announced the acquisition of, through a helicopter supported staking program, 69 State of Alaska mining claims, covering 11,040 acres. UAMY personnel were attracted to the area upon the recommendation of consulting geologists who had many years of Alaskan field experience, and by studying historical State of Alaska geological reconnaissance, mapping, sampling and assaying reports. One of the prime targets of the staking program was an 8-foot-wide quartz vein with very high copper values that the company geologists had previously examined. Assay values of 13 samples collected by the State geologists, from the quartz vein averaged 16.5% copper with 0.076 opt gold and 2.21 opt silver. Copper is one of the minerals on the U.S. Department of Energy Critical Minerals List. Access to this high-grade copper exposure is particularly favorable in open to moderate terrain. The company's consulting geologists were able to drive to within walking distance of the quartz vein via 10 miles of existing resource roads from a major highway.

08:04 EDT Tempest Therapeutics appoints Troy Wagner as VP, quality assurance - Tempest Therapeutics announced the appointment of Troy M. Wagner as Vice President of Quality Assurance. Prior to Tempest, she was the Vice President of Quality Assurance at Tricida, Inc., where she led all quality assurance functions for manufacturing, testing, holding and distribution activities.

08:02 EDT Lexicon announces FDA advisory committee meeting for Zynquista - Lexicon Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, expects to convene a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee for Zynquista as an adjunct to insulin therapy for glycemic control in adults with type 1 diabetes and chronic kidney disease on October 31, 2024, with no change to the PDUFA goal date of December 20, 2024. According to the notice provided, the FDA intends to make the background materials available to the public no later than two business days before the meeting.

08:01 EDT Monopar Therapeutics receives HREC clearance in Australian for MNP-101L-u study - Monopar Therapeutics announced it has received Human Research Ethics Committee, HREC, clearance in Australia to commence a Phase 1 therapeutic trial of its novel radiopharmaceutical MNPR-101-Lu. MNPR-101-Lu combines the therapeutic radioisotope lutetium-177 with Monopar's proprietary first-in-class humanized monoclonal antibody MNPR-101, which is highly selective against the urokinase plasminogen activator receptor. The MNPR-101-Lu Phase 1 clinical trial will enroll patients with advanced solid cancers and will be a therapeutic follow-on study to the currently ongoing MNPR-101-Zr imaging and dosimetry clinical trial.

07:35 EDT Rekor Systems secures SOC2 Type II certification - Rekor Systems announced that its Rekor Scout and Rekor Discover platforms have completed the Service Organization Control 2 Type II audit, joining the already SOC 2 compliant Rekor Command platform. This achievement highlights Rekor's ongoing commitment to the highest standards of security and operational excellence.

07:33 EDT Telephone and Data subsidiary to transfer ownership of cable operations in Texas - TDS Telecommunications has entered into a purchase agreement with Poka Lambro Telecommunications and Nevill Holdings to transfer ownership of its cable operations in Texas. The joint agreement includes the transfer of TDS' cable properties in Seminole, Seagraves, and Denver City to Poka Lambro and the cable properties in Alpine and Fort Stockton to Nevill Holdings, the parent company of Big Bend Telephone Company and Big Bend Telecom, or BBT. The agreement was signed Monday and is expected to close within the Q4. TDS, a Madison, Wisconsin-based company, has been doing business in Texas since 2013 when it acquired Baja Broadband who had been providing cable TV, voice, and internet service in Texas since 2005. Charlesmead Advisors served as advisors to buyers on the transaction. TDS Telecom is a subsidiary of Telephone and Data Systems.

07:32 EDT V2X secures $3.7B task order from U.S. Army - V2X announces a mission critical win to provide readiness capabilities to the U.S. Army worldwide under the Warfighter-Training Readiness Solutions task order. Valued at $3.7B over five years, including option periods, this task order further solidifies V2X's leading role in enabling full spectrum readiness for every soldier and unit across the U.S. Army. At the heart of this initiative is the mission enablement services for the Army's expansive network of Training Aids Devices Simulations and Simulators. V2X will provide a flexible enterprise solution that will seamlessly support hundreds of thousands of these critical devices worldwide, evolving warfighter training needs.

07:30 EDT Cardinal Health expands medical product distribution footprint in Northeast Ohio - Cardinal Health announced its plans to open a new distribution center in Walton Hills, Ohio, supporting its U.S. Medical Products and Distribution business. The facility will integrate new technology solutions, deliver operational efficiencies, and provide expanded capacity in the Cleveland, Ohio area. With construction underway, the distribution center is anticipated to be fully operational in the spring of 2025 and, at nearly 249,000 square feet, is more than 30% larger than the Cardinal Health location in nearby Solon, Ohio, it will replace. The larger building and its operations will accommodate a full transition of employees.

07:18 EDT Vicinity Motor enters workout agreement to develop restructuring plan - Vicinity Motor has reached an agreement with its secured lenders to execute a workout and financial restructuring plan to address the previously announced demands from Royal Bank of Canada and Export Development Canada in respect of outstanding credit facilities to progress towards financial stability for the Company. Vicinity and the Secured Lenders have agreed to the terms of the workout for the next 60 days, discussing with the Secured Lenders its revenues, debt structures, and initiatives to reorganize. During this period, the Company will return to limited operations and the Secured Lenders will retain all rights previously asserted. Prior to the conclusion of the workout period, Vicinity expects to have entered into a restructuring plan that may include agreements for payment and creditor rights and protections. During this period Vicinity will work to preserve the value of its assets, execute in process deliveries, and facilitate technical and parts support programs. The Company will continue to work closely with vendors, customers, and partners during this period as it endeavors to return to normal full operations within the 60-day period.

07:12 EDT Macy's falls 8% to $16.30 after lowering FY24 revenue, SSS guidance

07:10 EDT ADT Inc. appoints Yoon to board of directors - ADT announced the appointment of Suzanne Yoon to the Company's Board of Directors as an additional independent director. Yoon is the founder and managing partner of Kinzie Capital Partners, a Chicago-based private equity firm.

07:09 EDT Iridium appoints Vincent O'Neill as CFO - Iridium Communications announced that Thomas J. Fitzpatrick, the Company's CFO and Chief Administrative Officer and Bryan J. Hartin, 60, Executive Vice President, Sales and Marketing, plan to retire at year-end. Fitzpatrick will continue to serve on the Company's Board of Directors after his retirement as CFO. The Company named Vincent O'Neill as its new CFO and Timothy Last as the new Executive Vice President, Sales and Marketing, each to be effective January 1, 2025. Vincent O'Neill currently serves as Senior Vice President, Finance with responsibility for treasury, strategic and operational financial planning and execution. He joined Iridium in 2014 as its Vice President of Financial Planning and Analysis. Prior to joining Iridium, O'Neill was CFO of Mobilitie, a wireless infrastructure company, and previously spent 10 years at Nextel Sprint in a variety of senior finance roles. Prior to Nextel Sprint, he worked for Celnet, a Mobile Wireless Operator in the UK, now Telefonica. O'Neill is a Chartered Management Accountant and holds an Accounting and Finance Diploma from Technological University Shannon, Ireland.

07:09 EDT Chemomab Therapeutics sees cash runway through beginning of 2026 - Chemomab believes its existing liquidity resources as of June 30, 2024, together with the additional funds of approximately $10 million raised in July 2024, will enable the Company to fund its operations through the beginning of 2026.

07:07 EDT Arch Resources, Consol Energy to combine in all-stock merger of equals - Arch Resources (ARCH) and Consol Energy announced that they have entered into a definitive agreement to combine in an all-stock merger of equals to create Core Natural Resources, a premier North American natural resource company focused on global markets. Under the terms of the agreement, which has been unanimously approved by the Boards of Directors of both companies, Arch stockholders will receive a fixed exchange ratio of 1.326 shares of Consol common stock for each share of Arch common stock owned. Upon closing of the transaction, Core Natural Resources will trade under a new ticker. Arch stockholders will own approximately 45% of Core Natural Resources, and CONSOL stockholders will own approximately 55% on a fully diluted basis. The merger is expected to be tax-free to stockholders of both companies for U.S. federal income tax purposes. The merger is expected to close by the end of the first quarter of 2025, subject to approval by both companies' stockholders, regulatory approvals, and the satisfaction of other customary closing conditions. The transaction is expected to be accretive to free cash flow for both Arch and CONSOL in the first full year following close. The combination is expected to generate $110 million to $140 million of annual cost and operational synergies within six to 18 months following the close of the transaction, primarily from logistics optimization, coal blending and related opportunities, as well as procurement and SG&A efficiencies.

07:05 EDT Bio-Path provides update on ongoing Phase 1/1b trial of BP1001-A - Bio-Path Holdings provides an update from the Company's ongoing Phase 1/1b clinical trial of BP1001-A in solid tumor patients and reports continued patient progress from the Company's ongoing Phase 2 triple combination study of prexigebersen in Acute Myeloid Leukemia, AML. Bio-Path's first patient in the second dose cohort in its Phase 1/1b advanced solid tumor clinical trial experiencing a positive response may signal that this analog of prexigebersen has potential as a new treatment for advanced solid tumors. The patient appears to be doing well on study after failing extensive chemotherapy and surgical treatment for gynecologic cancer, demonstrating a 15% reduction in her primary tumor through six cycles of treatment. During the Company's recent pause for an interim analysis of results for Bio-Path's Phase 2 clinical trial treating AML patients, attention focused on two elderly patients who demonstrated continued treatment durability. The first patient is an elderly female who has received 16 cycles of treatment over 21 months and continues in complete remission. The second patient is an elderly male who is completing his twelfth cycle of treatment over fourteen months and continues in complete remission. The clinical trial investigator treating these two patients indicated that they are both doing very well on treatment

07:04 EDT Polestar announces Philipp Romers appointed Head of Design - Polestar announces that Philipp Romers has been appointed Head of Design... Philipp has over 25 years of experience in automotive design and joins Polestar from AUDI AG, where he has held a number of roles, including Head of Exterior Design. Before joining AUDI AG, he was a leading designer at Volkswagen AG.

07:03 EDT Ranchero enters LOI to sell Mexican subsidiary Paika - Ranchero Gold has entered into a letter of intent to sell its wholly-owned subsidiary Minera y Metalurgia Paika, S.A. de C.V. to an arm's length party purchaser for nil consideration. The sale of Paika, which includes four licenses totaling 16,876 hectares on the Santa Daniela project area, regional water rights and a conditional payment of US$2,500,000 pursuant to the sale by Paika of four mineral licenses to Minas de Oro Nacional, S.A. de C.V., a wholly-owned subsidiary of Alamos Gold as detailed in the Company's press release on June 19, 2024 will offset accrued liabilities in Paika of $3,545,852 of land fee payments and accrued interest due on the Santa Daniela mineral concessions along with a potential finder's fee in related to the Conditional Payment, as detailed in the press release of June 19, 2024. Under the terms of the transaction, the Liabilities will be assumed by the arm's length purchaser and will not be transferred to Ranchero or its associates and affiliates. The letter of intent is subject to the Company completing its due diligence. The parties intend that the letter of intent will be replaced by a definitive share purchase agreement between the parties to complete the sale of Paika. The Company announces that it has agreed to loan up to $30,000 to Toro Silver, a private British Columbia company. The principal amount of the Loan will accrue interest at a rate of 15% per annum. The outstanding balance of the Loan will be repayable upon demand of the Company after December 31, 2024. The Company will advance the Loan to Toro to pay for the audit of Toro's financial statements. The Loan is evidenced by the terms of a demand promissory note between the Company and Toro. The Loan is subject to the approval of the TSX Venture Exchange.

07:02 EDT Axsome Therapeutics reaches agreement to dismiss patent litigation with Sandoz - Axsome Therapeutics (AXSM) announced that it has reached agreement with Sandoz (SDZNY) to dismiss the patent litigation related to Axsome's product Sunosi. The litigation, which was pending in the United States District Court for the District of New Jersey, resulted from submission by Sandoz of an Abbreviated New Drug Application, ANDA, to the U.S. Food and Drug Administration seeking approval to market a generic equivalent of Sunosi in the United States. Sandoz withdrew its ANDA for a generic equivalent of Sunosi, and, as a result, the litigation has been dismissed without prejudice.

06:59 EDT Macy's reports Q2 gross margin rate 40.5%, up 240 bps - Merchandise margin increased 210 basis points driven by lower year over year discounting, favorable shortage due to the company's asset protection work, and partially by the company's shift to cost accounting. Delivery expense as a percent of net sales improved 30 basis points driven by lower shipped sales volumes and improved delivery expense control reflecting cost savings and process re-engineering initiatives.

06:51 EDT JD.com reports having fully utilized $3B repurchase amount authorized - In a regulatory filing, JD.com disclosed that it conducted share repurchase for a total price of approximately $390M on August 21, and has fully utilized the repurchase amount authorized under its $3.0B share repurchase program approved in March 2024.

06:33 EDT Bitfarms to acquire Stronghold Digital Mining in a stock-for-stock merger - Bitfarms (BITF) and Stronghold Digital Mining (SDIG) have entered into a definitive merger agreement under which Bitfarms will acquire Stronghold in a stock-for-stock merger transaction. The Transaction is valued at approximately $125M equity value plus the assumption of debt valued at approximately $50M. Stronghold is a vertically integrated crypto asset mining company focused on mining Bitcoin and environmental remediation and reclamation services. The Transaction has been unanimously approved by the Boards of Directors of both companies and is expected to close in the first quarter of 2025, subject to the receipt of Stronghold shareholder approval, applicable regulatory approvals, certain third-party consents and other customary closing conditions. Upon closing, Beard will contribute to the combined company in an advisory capacity. Under the terms of the Merger Agreement, Stronghold shareholders will receive 2.52 shares of Bitfarms for each share of Stronghold they own, representing consideration per share of $6.02 and a 71% premium to the Stronghold 90-day volume-weighted average price on Nasdaq as of August 16, 2024. At close, Stronghold shareholders are expected to own just under 10% of the combined company, based on the current issued and outstanding shares of each company. The Transaction delivers compelling transaction economics while achieving an estimated $10M in annual run-rate cost synergies.

06:15 EDT U.K.'s CMA closes probe into Apple's in-app payment system - The U.K.'s CMA announced that it has closed its Competition Act 1998 investigation into Apple's conduct in relation to the distribution of apps on iOS and iPadOS devices in the U.K. on administrative priority grounds. The CMA will continue to monitor Apple's conduct in the market. Its decision to close the case on grounds of administrative priority does not prevent, pre-judge or fetter the CMA's ability, if appropriate, to open an investigation under the Chapter II prohibition in future, or to take action in respect of the conduct considered as part of the Investigation under the powers it has now gained in the Digital Markets, Competition and Consumers Act 2024 or its other tools.

06:10 EDT U.K.'s CMA: 'Not appropriate' to accept commitments offered by Google - The U.K.'s Competition and Markets Authority announced that it has closed its Competition Act 1998 investigation into Google's conduct in relation to Google's distribution of apps on Android devices in the U.K. on administrative priority grounds. Having considered representations received in response to the 2023 commitments consultation, the CMA decided that it would not be appropriate to accept the commitments offered by Google. Reference Link

06:06 EDT Full Truck Alliance sees Q3 revenue up 21.9%-24.6% - The company said, "The Company expects its total net revenues to be between RMB2.76 billion and RMB2.82 billion for the third quarter of 2024, representing a year-over-year growth rate of approximately 21.9% to 24.6%. These forecasts reflect the Company's current and preliminary views on the market and operational conditions, which are subject to change and cannot be predicted with reasonable accuracy as of the date hereof."

06:05 EDT reAlpha appoints William Brent Miller as CFO - reAlpha Tech (AIRE) announced the appointment of William Brent Miller as the Company's CFO, effective as of August 19, replacing Michael J. Logozzo from his role as Interim CFO. Miller will assume responsibility for all financial and accounting functions of the Company and will report directly to its President and COO, Logozzo. Miller brings over 20 years of finance reporting and leadership skills. Before joining the Company, from January 2019 to March Miller served as Chief Accounting Officer of Sunlight Financial Holdings, a previously publicly traded technology-enabled point-of-sale finance company that provides homeowners with financing for the installation of residential solar systems and other home improvements. Mr. Miller managed Sunlight's financial reporting, accounting policy and procedures and internal controls. Prior to Sunlight, from October 2015 to March 2018, Miller served as CFO and Treasurer of KKR Real Estate Finance Trust, a commercial mortgage real estate investment trust externally managed by Kohlberg Kravis Roberts & Co. (KKR), a global investment firm, where he oversaw all aspects of the REIT's financial and organizational strategy involving capital raises, capital structure and financial and regulatory reporting.

06:02 EDT Vector Group to be acquired by JT Group for $2.4B - Vector Group announced that it has entered into a definitive agreement to be acquired by JT Group, a global company headquartered in Tokyo, Japan, operating in tobacco, pharmaceuticals and processed food. Under the terms of the agreement, JT Group will offer to acquire all outstanding shares of Vector Group common stock for $15.00 per share in cash, which represents a premium of 29.9% over the 60-day volume-weighted average share price, or approximately $2.4B of total equity value, in addition to redemption or repayment of debt, through a tender offer and second-step merger. The Boards of Directors of both companies have unanimously approved the merger agreement. Details regarding the process will be available in Vector Group's Recommendation Statement for the tender offer, which Vector Group will file shortly with the SEC. After closing, Vector Group will become a wholly owned subsidiary of JT Group. The transaction is subject to customary closing conditions, including the tender of a majority of the outstanding shares of Vector Group and the receipt of applicable regulatory approvals. The transaction is expected to close in the Q4. Jefferies served as exclusive financial advisor and Sullivan & Cromwell served as legal advisor to Vector Group. J.P. Morgan Securities and J.P. Morgan Securities are serving as exclusive financial advisor to JT Group, Ernst & Young Tax is acting as its financial and tax advisor and Freshfields Bruckhaus Deringer US LLP is acting as its legal advisor.

05:07 EDT Altair Engineering, Oasys announce joint development agreement - Altair and Oasys announced a joint development agreement to deliver an integrated solution for safety simulation modeling in the automotive market.